LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Search

Co-Diagnostics Inc

Slēgts

SektorsVeselības aprūpe

0.27 -15.62

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.27

Max

0.32

Galvenie mērījumi

By Trading Economics

Ienākumi

-197K

-7.7M

Pārdošana

113K

163K

Peļņas marža

-4,745.023

Darbinieki

132

EBITDA

-526K

-7.8M

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 6. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

4.2M

13M

Iepriekšējā atvēršanas cena

15.89

Iepriekšējā slēgšanas cena

0.27

Ziņu noskaņojums

By Acuity

39%

61%

130 / 371 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

Co-Diagnostics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 2. sept. 23:07 UTC

Iegādes, apvienošanās, pārņemšana

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2025. g. 2. sept. 22:10 UTC

Galvenie tirgus virzītāji

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2025. g. 2. sept. 21:47 UTC

Peļņas

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2025. g. 2. sept. 16:52 UTC

Galvenie tirgus virzītāji

CleanCore Solutions Shares Drop After $175 Million Private Investment

2025. g. 2. sept. 22:47 UTC

Tirgus saruna

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2025. g. 2. sept. 21:40 UTC

Iegādes, apvienošanās, pārņemšana

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2025. g. 2. sept. 21:07 UTC

Peļņas

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2025. g. 2. sept. 21:07 UTC

Peļņas

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2025. g. 2. sept. 21:05 UTC

Peļņas

Couche-Tard 1Q Rev $17.35B >ATD.T

2025. g. 2. sept. 21:05 UTC

Peļņas

Couche-Tard 1Q Adj EPS 78c >ATD.T

2025. g. 2. sept. 21:05 UTC

Peļņas

Couche-Tard 1Q EPS 82c >ATD.T

2025. g. 2. sept. 21:05 UTC

Peļņas

Couche-Tard 1Q Net $782.5M >ATD.T

2025. g. 2. sept. 21:00 UTC

Tirgus saruna

ESG Roundup: Market Talk

2025. g. 2. sept. 20:53 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2025. g. 2. sept. 20:51 UTC

Iegādes, apvienošanās, pārņemšana

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2025. g. 2. sept. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 2. sept. 20:27 UTC

Peļņas

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2025. g. 2. sept. 20:24 UTC

Iegādes, apvienošanās, pārņemšana

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2025. g. 2. sept. 20:18 UTC

Iegādes, apvienošanās, pārņemšana

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2025. g. 2. sept. 20:17 UTC

Iegādes, apvienošanās, pārņemšana

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2025. g. 2. sept. 20:16 UTC

Iegādes, apvienošanās, pārņemšana

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2025. g. 2. sept. 20:16 UTC

Iegādes, apvienošanās, pārņemšana

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2025. g. 2. sept. 20:15 UTC

Iegādes, apvienošanās, pārņemšana

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2025. g. 2. sept. 19:55 UTC

Peļņas

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2025. g. 2. sept. 19:50 UTC

Iegādes, apvienošanās, pārņemšana

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2025. g. 2. sept. 19:09 UTC

Tirgus saruna

Oil Futures Gain on Geopolitical Premium -- Market Talk

2025. g. 2. sept. 19:00 UTC

Tirgus saruna

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2025. g. 2. sept. 18:12 UTC

Tirgus saruna

Gold Pushes To New Record -- Market Talk

2025. g. 2. sept. 17:04 UTC

Tirgus saruna

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2025. g. 2. sept. 16:57 UTC

Iegādes, apvienošanās, pārņemšana

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Co-Diagnostics Inc Prognoze

Vērtējuma vienprātība

By TipRanks

Neitrāls

1 ratings

0

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

0.3495 / 0.3699Atbalsts un pretestība

Īstermiņā

Bearish Evidence

Vidējā termiņā

Weak Bearish Evidence

Ilgtermiņā

No Evidence

Noskaņojums

By Acuity

130 / 371 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.